Skip to content
Search

Latest Stories

Community Pharmacy Scotland issues guidance on wearing face coverings

Following the Scottish government’s announcement that face coverings will be mandatory in enclosed indoor spaces, including pharmacies, from July 10, Community Pharmacy Scotland (CPS) has issued guidance for pharmacy teams.

The supplementary information published on Tuesday (July 7) for pharmacy teams says:


  • Enforcement: this will be carried out by the police, with no expectation that pharmacy team members carry out this duty. No tasers.
  • There are some exceptions to the law for those who cannot wear a face covering due to existing health conditions – but it is not a definitive list e.g. everyone with COPD. Each individual will make their own assessment of whether they can reasonably wear a mask, and again any challenge to these decisions is for the police to make.
  • You may, however, wish to remind people of the law change – whether to further reduce the risk to your team and other patients or to help individuals avoid fines

However, if workers are physically separated by a screen from customers, then the team members do not have to wear a face covering.

The CPS has also released a poster to covey the importance of wearing face in community pharmacies and and other retail settings.

Speaking in a Covid-19 press briefing last week, First Minister Nicola Sturgeon said it would be mandatory for the people to wear a face covering in shops as part of the Phase Three coronavirus restrictions.

The government’s latest move follows successful introduction of mandatory face coverings on public transport, in line with expected changes to other lockdown measures.

More For You

Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less
After US and EU, UK approves Bavarian Nordic’s chikungunya vaccine

Bavarian Nordic plans to launch the vaccine in the UK in summer 2025

Getty Images

Chikungunya vaccine Vimkunya approved for use in the UK

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for Vimkunya, a vaccine developed by Bavarian Nordic A/S to prevent chikungunya disease in people aged 12 years and older.

The UK approval follows earlier approvals by the U.S. Food and Drug Administration (FDA) and the European Commission in February 2025, making this the third regulatory green light for the vaccine.

Keep ReadingShow less
NICE approves once-daily tablet Linzagolix for endometriosis

NICE recommends Linzagolix with add-back therapy for endometriosis

Image credit: Getty Images

NICE approves new at-home treatment for endometriosis

The National Institute for Health and Care Excellence (NICE) has recommended Linzagolix (brand name Yselty), a once-daily tablet, as a new treatment option for endometriosis.

Developed by Theramex, Linzagolix is approved for use alongside hormonal add-back therapy in adults of reproductive age who have previously tried other medical or surgical treatments for the condition.

Keep ReadingShow less
Many patients report inaccuracies or missing details in their NHS medical records

Inaccurate information can result in serious harm or even death, warns Healthwatch England.

Image Credit: Getty Images

1 in 4 adults have spotted errors in their NHS medical records, survey finds

Healthwatch England has raised the alarm over the risks posed by inaccurate medical records as research reveals widespread errors in NHS patient information.

Commissioned by Healthwatch England and conducted by BMG Research, the survey polled a representative sample of 1,800 adults in England between 24 and 27 March 2025.

Keep ReadingShow less
RPS and HEIW extend independent prescribing learning programme for pharmacists in Wales

The programme is designed to support pharmacists delivering the Pharmacy Independent Prescribing Service in Wales.

gettyimages

Independent prescribing learning programme for pharmacists in Wales extended till 2028

The Royal Pharmaceutical Society (RPS) and Health Education and Improvement Wales (HEIW) have announced a three-year extension of their successful learning programme designed to support pharmacists delivering the Pharmacy Independent Prescribing Service (PIPS) in Wales.

Originally launched in 2024, the programme equips pharmacists with the essential knowledge, skills, and confidence needed to provide excellent patient care as independent prescribers.

Keep ReadingShow less